Back to search

University of British Columbia

Vaccination against gammaherpesvirus attenuates viral enhanced disease in a murine model of multiple sclerosis

Abstract

dc:description

Multiple Sclerosis (MS) is a chronic, neurodegenerative autoimmune disease of the central nervous system (CNS). The aetiology of the disease remains unknown; however, it is thought to be a combination of environmental factors in genetically susceptible individuals. One such environmental factor is infection with Epstein-Barr virus (EBV), a DNA virus of the gammaherpesvirus family that infects over 95% of individuals worldwide. Following primary infection, EBV establishes a life-long latent infection in the host’s B cells. MS does not develop in the absence of EBV exposure, and EBV is necessary, but insufficient on its own, to cause disease. In a mouse model of EBV and MS, latent infection of mice with γ-herpesvirus-68 (γHV68), the murine homologue of EBV, exacerbates the clinical and immunological outcomes of experimental autoimmune encephalomyelitis (EAE), a common mouse model for MS. The compelling evidence supporting EBV infection as a co-factor in the development of MS has sparked interest in the potential of EBV-targeted therapies to treat the disease, for example by preventing or controlling primary EBV infection using a prophylactic vaccine. As such, mice were vaccinated against, and then challenged with, γHV68, which successfully reduced the viral load of γHV68 latent infection. Mice were subsequently induced with EAE. Vaccinated mice displayed an attenuation of viral-enhanced disease, and early in the course of EAE, vaccinated mice displayed significantly reduced CNS immune infiltration compared to unvaccinated mice. This work demonstrates the potential for vaccination against EBV to prevent or ameliorate MS and highlights the urgency and necessity for the development of an EBV vaccine.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Microbiology and Immunology
Grantor dc:publisher
University of British Columbia
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Rosen, Ariel R.
Contributors dc:contributor
  • Horwitz, Marc S.

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/88496

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Rosen, Ariel R.. Vaccination against gammaherpesvirus attenuates viral enhanced disease in a murine model of multiple sclerosis. master's thesis, University of British Columbia, 2024. http://hdl.handle.net/2429/88496